ArticlePloS one2010

Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.

Sandhya Vasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.